Microsoft Health: A New Thrust
June 4, 2009
Shift your attention from Bing.com to a sector that is a must-win for Microsoft. Ina Fried reported here that Microsoft acquired Rosetta Biosoftware from the struggling pharmaceutical company, Merck. Rosetta Biosoftware is a unit of of Rosetta Inpharmatics. Based in Seattle, the 300 person firm had been hit with cutbacks due to the financial climate. The software unit, which had about 60 employees, was expected to keep it lights on. According to Ms. Fried’s “Microsoft Buys Merck Unit in Life Sciences Push” here,
Microsoft, which has a separate Amalga product family for hospitals, announced in April that it would offer Microsoft Amalga Life Sciences as an effort to help in the drug research software arena. The tools are designed to help manage and analyze the large amounts of data gathered in the process of designing new drugs.
What’s Rosetta Biosoftware’s business? According to a profile here, the company
develops informatics solutions and provides services that enable research organizations to efficiently and effectively conduct life-saving discoveries and develop drugs.
Microsoft’s Amalga, according to Microsoft here, the company
develops its own powerful health solutions, such as Amalga and HealthVault. Together, Microsoft and its industry partners are working to advance a vision of unifying health information and making it more readily available, ensuring the best quality of life and affordable care for everyone.
Looks to me as if the dust up between Microsoft and Google in the health sector is likely to become more intense.
Stephen Arnold, June 3, 2009
Comments
-
- Subscribe to Beyond Search
Feature archive
News archive
-
